Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Nuclear Medicine

Free Subscription 15.07.2024 1 AJNR Am J Neuroradiol 2 Ann Neurol 2 Ann Nucl Med 1 BMC Neurol 3 Clin Nucl Med 3 J Nucl Med 1 Lancet 2 Neurology 1 Nucl Med Commun 2 Phys Med Biol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. MITCHELLE A, Gorolay VV, Aitken M, Hanneman K, et al
   CTP for the Screening of Vasospasm and Delayed Cerebral Ischemia in Aneurysmal SAH: A Systematic Review and Meta-analysis.
   AJNR Am J Neuroradiol. 2024;45:871-878.
   PubMed         Abstract available
   
   

   
   Ann Neurol

2. HIRATA K, Matsuoka K, Tagai K, Endo H, et al
   In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy.
   Ann Neurol. 2024;96:247-261.
   PubMed         Abstract available
   
   
3. SAARINEN EK, Kuusimaki T, Lindholm K, Niemi K, et al
   Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease.
   Ann Neurol. 2024 May 20. doi: 10.1002/ana.26957.
   PubMed         Abstract available
   
   

   
   Ann Nucl Med

4. ARCAY OZTURK A, Erkilic M, Bural GG, Aydin F, et al
   Physiological biodistribution on Ga68-PSMA PET/CT and the factors effecting biodistribution.
   Ann Nucl Med. 2024 Jul 9. doi: 10.1007/s12149-024-01957.
   PubMed         Abstract available
   
   
5. SHIMIZU Y, Ando M, Watanabe H, Ono M, et al
   Novel technetium-99m-labeled bivalent PSMA-targeting probe based on hydroxamamide chelate for diagnosis of prostate cancer.
   Ann Nucl Med. 2024 Jul 8. doi: 10.1007/s12149-024-01959.
   PubMed         Abstract available
   
   

   
   BMC Neurol

6. HU Q, Shi M, Li Y, Zhao X, et al
   Elevated plasma neurofilament light was associated with multi-modal neuroimaging features in Alzheimer's disease signature regions and predicted future tau deposition.
   BMC Neurol. 2024;24:236.
   PubMed         Abstract available
   
   

   
   Clin Nucl Med

7. HUANG S, Liu H, Dai H, Qi M, et al
   Comparison of 68Ga-FAPI-04 and 18F-FDG PET/CT in Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Prospective and Single-Center Study.
   Clin Nucl Med. 2024 Jul 10. doi: 10.1097/RLU.0000000000005367.
   PubMed         Abstract available
   
   
8. JAIN V, McIntosh L
   Subacute Cerebral Infarct: An Unusual Cause of Radiotracer Uptake at 18F-PSMA PET/CT.
   Clin Nucl Med. 2024 Jul 8. doi: 10.1097/RLU.0000000000005373.
   PubMed         Abstract available
   
   
9. LIN CY, Chang MC, Kao CH
   Comparing the Diagnostic Value of FDG PET or PET/CT With FDG PET/MR in Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.
   Clin Nucl Med. 2024 Jul 8. doi: 10.1097/RLU.0000000000005379.
   PubMed         Abstract available
   
   

   
   J Nucl Med

10. CLEMENT C, Leclere JC, Maheo C, Le Pennec R, et al
    Diagnostic Performance of (18)F-FDG PET/CT According to Delay After Treatment to Detect Subclinical Recurrence of Head and Neck Squamous Cell Carcinoma.
    J Nucl Med. 2024 Jul 11:jnumed.124.267391. doi: 10.2967/jnumed.124.267391.
    PubMed         Abstract available
    
    
11. LARIVE T, Boursier C, Claudin M, Varlot J, et al
    Factors Associated with Myocardial Uptake on Oncologic Somatostatin PET Investigations and Differentiation from Myocardial Uptake of Acute Myocarditis.
    J Nucl Med. 2024 Jul 11:jnumed.123.267219. doi: 10.2967/jnumed.123.267219.
    PubMed         Abstract available
    
    
12. KANG F, Xie Z, Ma W, Quan Z, et al
    Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System.
    J Nucl Med. 2024 Jul 11:jnumed.124.267446. doi: 10.2967/jnumed.124.267446.
    PubMed         Abstract available
    
    

    
    Lancet

13. BORCHMANN P, Ferdinandus J, Schneider G, Moccia A, et al
    Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial.
    Lancet. 2024 Jul 3:S0140-6736(24)01315-1. doi: 10.1016/S0140-6736(24)01315.
    PubMed         Abstract available
    
    

    
    Neurology

14. VAN DER VEERE PJ, Hoogland J, Visser LNC, Van Harten AC, et al
    Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia.
    Neurology. 2024;103:e209605.
    PubMed         Abstract available
    
    
15. NISHIDA A, Shima A, Kambe D, Furukawa K, et al
    Frontoparietal-Striatal Network and Nucleus Basalis Modulation in Patients With Parkinson Disease and Gait Disturbance.
    Neurology. 2024;103:e209606.
    PubMed         Abstract available
    
    

    
    Nucl Med Commun

16. GUO L, Wang R, Shen G
    Fluorine-18 fluorodeoxyglucose uptake change in liver, mediastinal blood pool, and lymphoid cell-rich organs during programmed cell death-1 immunotherapy in lymphoma.
    Nucl Med Commun. 2024;45:718-726.
    PubMed         Abstract available
    
    

    
    Phys Med Biol

17. XIE T, Cui Z, Luo C, Wang H, et al
    Joint diffusion: mutual consistency-driven diffusion model for PET-MRI co-reconstruction.
    Phys Med Biol. 2024 Jul 9. doi: 10.1088/1361-6560/ad6117.
    PubMed         Abstract available
    
    
18. DUAN C, Liu Q, Wang J, Tong Q, et al
    GWO+RuleFit: rule-based explainable machine-learning combined with heuristics to predict mid-treatment FDG PET response to chemoradiation for locally advanced non-small cell lung cancer.
    Phys Med Biol. 2024 Jul 9. doi: 10.1088/1361-6560/ad6118.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.